National Perox.

  • Market Cap: Micro Cap
  • Industry: Commodity Chemicals
  • ISIN: INE0PO601011
  • NSEID:
  • BSEID: 544205
INR
442.50
7.2 (1.65%)
BSENSE

Feb 11

BSE+NSE Vol: 2504

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryPrice Point
High/Low

1Day

52 Week

Valuation
Technical
Day's Volume

CASH

2.5 k (13.80%) Volume

Shareholding (Dec 2025)

FII

0.00%

Held by 0 FIIs

DII

0.01%

Held by 0 DIIs

Promoter

70.76%

Has National Perox. declared dividend?

06-Jun-2025

Yes, National Peroxide Ltd has declared a 125% dividend, amounting to ₹12.5 per share, with an ex-date of August 20, 2024. However, the company's total returns have been negative in the last 6 months and stagnant over the past several years.

National Peroxide Ltd has declared a 125% dividend.<BR><BR>Dividend Details:<BR>- Percentage announced: 125%<BR>- Amount per share: 12.5<BR>- Ex-date: 20 Aug 24<BR><BR>Dividend Yield: 2.05%.<BR><BR>Total Returns by Period:<BR>In the last 6 months, the price return was -30.82%, the dividend return was 0%, resulting in a total return of -30.82%.<BR><BR>Over the past year, there was no price return, no dividend return, leading to a total return of 0.0%.<BR><BR>In the 2-year period, the price return remained at 0%, with no dividend return, resulting in a total return of 0.0%.<BR><BR>For the 3-year period, the price return was 0%, with no dividend return, resulting in a total return of 0.0%.<BR><BR>In the 4-year period, there was a price return of 0%, no dividend return, leading to a total return of 0.0%.<BR><BR>Finally, in the 5-year period, the price return was 0%, with no dividend return, resulting in a total return of 0.0%.<BR><BR>Overall, while National Peroxide Ltd has declared a significant dividend, the total returns over various periods indicate a challenging performance, particularly in the short term with a notable decline in price return.

View full answer

Is National Perox. overvalued or undervalued?

09-Jun-2025

As of May 7, 2025, National Perox. is considered overvalued and risky, with a PE ratio of -157.63 and negative EV ratios, indicating poor financial performance compared to peers like Solar Industries and Godrej Industries, despite a recent stock return of 8.61%.

As of 7 May 2025, the valuation grade for National Perox. has moved from attractive to risky, indicating a significant shift in its financial outlook. The company is currently considered overvalued. Key ratios highlight this concern: the PE ratio stands at an alarming -157.63, while the EV to EBIT ratio is also negative at -64.72, and the EV to EBITDA ratio is at 20.91. These figures suggest that the company is struggling to generate profits relative to its valuation.<BR><BR>In comparison to its peers, National Perox. shows stark contrasts. For instance, Solar Industries India Ltd. has a PE ratio of 123.77, while Godrej Industries Ltd. boasts a PE ratio of 46.63, both indicating much stronger valuations. Additionally, National Perox.'s ROE is at -0.63%, further emphasizing its underperformance relative to the industry. Despite a recent stock return of 8.61% over the past week, which outperformed the Sensex's 1.35%, the overall financial metrics suggest that investors should approach National Perox. with caution.

View full answer

What is the technical trend for National Perox.?

09-Jun-2025

As of June 6, 2025, National Perox's technical trend has shifted to a moderate bearish stance, indicated by daily moving averages and weekly KST readings, despite some mixed signals from the Dow Theory and weekly MACD.

As of 6 June 2025, the technical trend for National Perox has changed from mildly bearish to bearish. The current stance is bearish with a moderate strength. Key indicators include the daily moving averages showing a mildly bearish trend, while the weekly KST is bearish. The Dow Theory indicates a mildly bullish stance on the weekly but remains bearish on the monthly, suggesting mixed signals. The MACD on the weekly is mildly bullish, but the overall sentiment leans bearish due to the prevailing moving averages and KST readings.

View full answer

Who are the peers of the National Perox.?

16-Jul-2025

Peers of National Perox. include Primo Chemicals, Vikram Thermo, Mangalam Organic, Andhra Petrochem, Lords Chloro, Kanoria Chem., Alufluoride, Kesar Petroprod., and Hind.Organ.Chem. National Perox. has an average management risk and a 1-year return of -48.53%, higher than Andhra Petrochem's -52.23% but lower than Kesar Petroprod.'s 59.06%.

Peers: The peers of National Perox. are Primo Chemicals, Vikram Thermo, Mangalam Organic, Andhra Petrochem, Lords Chloro, Kanoria Chem., Alufluoride, Kesar Petroprod., and Hind.Organ.Chem.<BR><BR>Quality Snapshot: Excellent management risk is observed at Vikram Thermo and Alufluoride, while Average management risk is found at Primo Chemicals, Mangalam Organic, Andhra Petrochem, Lords Chloro, National Perox., Kesar Petroprod., and Sadhana Nitro, and Below Average management risk is noted at Kanoria Chem. and Hind.Organ.Chem. Growth is rated as Excellent for Alufluoride, Good for Vikram Thermo and Kesar Petroprod., Average for Primo Chemicals, Mangalam Organic, Andhra Petrochem, Lords Chloro, National Perox., and Sadhana Nitro, and Below Average for Kanoria Chem. and Hind.Organ.Chem. Capital Structure is Excellent for Andhra Petrochem, Good for National Perox. and Alufluoride, Average for Primo Chemicals, Mangalam Organic, Lords Chloro, and Kesar Petroprod., and Below Average for Kanoria Chem. and Hind.Organ.Chem.<BR><BR>Return Snapshot: The peer with the highest 1-year return is Kesar Petroprod. at 59.06%, while the lowest is Andhra Petrochem at -52.23%. National Perox.'s own 1-year return is -48.53%, which is higher than Andhra Petrochem's but lower than Kesar Petroprod.'s. Additionally, the peers with negative six-month returns include Primo Chemicals, Andhra Petrochem, Kanoria Chem., Alufluoride, and Hind.Organ.Chem.

View full answer

What does National Perox. do?

17-Jul-2025

National Peroxide Ltd is a micro-cap company in the commodity chemicals industry, reporting net sales of 737 Cr and a net loss of 65 Cr for the quarter ending March 2025. The company has a market cap of INR 407 Cr and a dividend yield of 1.81%.

Overview:<BR>National Peroxide Ltd operates in the commodity chemicals industry and is classified as a micro-cap company.<BR><BR>History:<BR>The company was incorporated in 2020 as NPL Chemicals Limited and later changed its name to National Peroxide Limited following a Composite Scheme of Arrangement. The latest quarterly results reported net sales and net profit for the period ending March 2025.<BR><BR>Financial Snapshot:<BR>Most recent Net Sales: 737 Cr (Quarterly Results - Mar 2025) <BR>Most recent Net Profit: -65 Cr (Quarterly Results - Mar 2025) <BR>Market-cap value: INR 407 Cr (Micro Cap)<BR><BR>Key Metrics:<BR>P/E: N/A <BR>Industry P/E: 47 <BR>Dividend Yield: 1.81% <BR>Debt-Equity: -0.10 <BR>Return on Equity: -0.63% <BR>Price to Book: 1.11<BR><BR>Contact Details:<BR>No Company Details Available <BR>Registrar Address: Not available.

View full answer

Who are the top shareholders of the National Perox.?

17-Jul-2025

The top shareholders of National Perox include Nowrosjee Wadia And Sons Limited with 30.78% and individual investors with 24.82%. There are no mutual funds or foreign institutional investors holding shares in the company.

The top shareholders of National Perox include the promoters, with Nowrosjee Wadia And Sons Limited holding the largest stake at 30.78%. Additionally, individual investors collectively hold 24.82% of the shares. There are currently no mutual funds or foreign institutional investors (FIIs) holding shares in the company.

View full answer

How big is National Perox.?

24-Jul-2025

As of 24th July, National Peroxide Ltd has a market capitalization of 397.00 Cr and reported net sales of 286.87 Cr with a net loss of 2.25 Cr over the latest four quarters. Shareholder's funds are valued at 358.96 Cr, with total assets of 459.33 Cr as of March 2024.

As of 24th July, <BR><BR>Market Cap: National Peroxide Ltd has a market capitalization of 397.00 Cr, classified as a Micro Cap.<BR><BR>Recent Quarterly Performance: The sum of Net Sales for the latest 4 quarters is 286.87 Cr, while the sum of Net Profit for the same period reflects a loss of 2.25 Cr.<BR><BR>Balance Sheet Snapshot: The reporting period for the balance sheet is March 2024. Shareholder's Funds are valued at 358.96 Cr, and Total Assets amount to 459.33 Cr.

View full answer

How has been the historical performance of National Perox.?

03-Nov-2025

National Perox has experienced a significant decline in financial performance over the past three years, with net sales dropping from 375.87 Cr in March 2023 to 286.87 Cr in March 2025, resulting in a loss of -2.25 Cr in profit after tax. Key metrics such as operating profit and earnings per share also fell sharply, indicating reduced profitability and cash generation capabilities.

Answer:<BR>The historical performance of National Perox shows a decline in key financial metrics over the past three years, culminating in a loss for the year ending March 2025.<BR><BR>Breakdown:<BR>National Perox's net sales decreased from 375.87 Cr in March 2023 to 286.87 Cr in March 2025, reflecting a downward trend in total operating income, which also fell from 375.87 Cr to 286.87 Cr during the same period. The company's total expenditure, excluding depreciation, decreased from 317.36 Cr in March 2023 to 271.66 Cr in March 2025, primarily due to a reduction in raw material costs from 191.26 Cr to 145.46 Cr. However, operating profit (PBDIT) declined significantly from 67.36 Cr in March 2023 to 19.70 Cr in March 2025, leading to a profit before tax of -2.08 Cr in March 2025, down from 53.50 Cr in March 2023. Consequently, profit after tax also turned negative, reaching -2.25 Cr in March 2025 compared to 39.50 Cr in March 2023. The company's earnings per share (EPS) reflected this downturn, dropping from 68.7 in March 2023 to -3.91 in March 2025. On the balance sheet, total liabilities decreased from 453.55 Cr in March 2023 to 441.72 Cr in March 2025, while total assets also fell from 453.55 Cr to 441.72 Cr. Cash flow from operating activities showed a decline from 67.00 Cr in March 2023 to 18.00 Cr in March 2025, indicating a significant reduction in cash generation capabilities. Overall, National Perox's financial performance has deteriorated over the past three years, resulting in losses and reduced profitability.

View full answer

When is the next results date for National Peroxide Ltd?

03-Feb-2026

The next results date for National Peroxide Ltd is February 5, 2026.

The next results date for National Peroxide Ltd is scheduled for February 5, 2026.

View full answer

Are National Peroxide Ltd latest results good or bad?

06-Feb-2026

National Peroxide Ltd's latest Q3 FY26 results show a significant net profit increase of 369.23% quarter-on-quarter and improved revenue, but concerns remain due to a history of losses, low return on equity, and a 40.21% decline in stock value over the past year, indicating mixed overall performance. Caution is advised regarding the company's future prospects.

National Peroxide Ltd's latest results for Q3 FY26 present a mixed picture. On one hand, the company reported a net profit of ₹1.83 crore, which is a significant improvement of 369.23% quarter-on-quarter. Additionally, revenue increased by 1.17% from the previous quarter, reaching ₹69.09 crore, and this marks an 11.15% increase year-on-year.<BR><BR>The operating margin also improved to 10.12%, the highest in seven quarters, suggesting some operational stability. However, this recovery comes after a challenging FY25, where the company faced a net loss of ₹2 crore on revenues of ₹286 crore, indicating a significant decline from a profit of ₹16 crore in FY24.<BR><BR>Despite these positive indicators, the overall financial health of National Peroxide remains concerning. The company has struggled with volatile margins, and its return on equity (ROE) is alarmingly low at 1.90%, with the latest quarterly ROE even dipping to -1.92%. The stock has underperformed significantly, with a one-year decline of 40.21%, contrasting sharply with the broader market's performance.<BR><BR>In summary, while there are some signs of recovery in the most recent quarter, the underlying issues, including poor historical performance and low investor confidence, suggest that the results are not entirely positive. Caution is warranted when assessing the company's future prospects.

View full answer

Should I buy, sell or hold National Peroxide Ltd?

06-Feb-2026

Why is National Peroxide Ltd falling/rising?

09-Feb-2026

As of 09-Feb, National Peroxide Ltd's stock price is currently at 426.20, reflecting a recent upward trend with a total return of 9.41% over the last five days. However, it has underperformed its sector today and shows significant declines year-to-date and over the past year.

As of 09-Feb, National Peroxide Ltd's stock price is rising, currently at 426.20, reflecting a change of 1.9 (0.45%) upward. This increase is notable as the stock has been on a gaining streak for the last five days, resulting in a total return of 9.41% during this period. Additionally, the stock reached an intraday high of Rs 434.7, which is a 2.45% increase from its previous price.<BR><BR>Despite this positive momentum, it is important to note that the stock has underperformed its sector by 2.69% today, and over the longer term, it has shown a decline of 8.93% year-to-date and 40.25% over the past year. However, the recent rise in investor participation, with a delivery volume increase of 31.13% against the 5-day average, indicates growing interest in the stock. Overall, the combination of recent gains, increased trading activity, and a positive sector performance in chemicals, which has gained by 3.15%, contributes to the current rise in National Peroxide Ltd's stock price.

View full answer
iScoreScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy

Dashboard

1

Poor long term growth as Net Sales has grown by an annual rate of -12.60% and Operating profit at -135.58% over the last 5 years

 
2

Risky - Negative Operating Profits

3

Below par performance in long term as well as near term

stock-summaryMojo Parameters

Mojo Parameters

Loading Valuation Snapshot...

Stock DNA

stock-summary
Industry

Commodity Chemicals

stock-summary
Market cap

INR 253 Cr (Micro Cap)

stock-summary
P/E

NA (Loss Making)

stock-summary
Industry P/E

40

stock-summary
Dividend Yield

0.00%

stock-summary
Debt Equity

-0.14

stock-summary
Return on Equity

-0.80%

stock-summary
Price to Book

0.71

Revenue and Profits:
Net Sales:
69 Cr
(Quarterly Results - Dec 2025)
Net Profit:
2 Cr
stock-summaryTotal Returns
Total Returns (Price + Dividend) stock-summary
Dividend Yield (0%)
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
-23.32%
0%
-23.32%
6 Months
-30.28%
0%
-30.28%
1 Year
-34.84%
0%
-34.84%
2 Years
0%
0%
0.0%
3 Years
0%
0%
0.0%
4 Years
0%
0%
0.0%
5 Years
0%
0%
0.0%

Latest dividend: 12.5 per share ex-dividend date: Aug-20-2024

Risk Adjusted Returns v/s stock-summary
Returns Beta
Icon
Beta has not been calculated since enough price history is not available
stock-summaryNews & Corporate Actions

News

Why is National Peroxide Ltd falling/rising?

Short-Term Price Performance and Market Context

National Peroxide Ltd has demonstrated a remarkable recovery over the past week, gaining 10.02%, significantly outperforming the Sensex’s modest 0.64% rise during the same period. This recent upswing contrasts with the stock’s one-month decline of 1.21% and a year-to-date drop of 7.05%, indicating that the current momentum is a rebound rather than a continuation of a longer-term uptrend. Over the past year, the stock has underperformed sharply, falling 37.71% compared to the Sensex’s 9.01% gain, highlighting the volatility and challenges faced by the company’s shares in the broader market context.

Despite this, the stock’s recent performance signals renewed investor confidence, as it has recorded gains for six consecutive...

Read full news article

Announcements stock-summary

Announcement under Regulation 30 (LODR)-Newspaper Publication

06-Feb-2026 | Source : BSE

Newspaper Advertisement for the unaudited financial results of the company for the Quarter and Nine months ended December 31 2025.

Appointment of Company Secretary and Compliance Officer

05-Feb-2026 | Source : BSE

The Company has informed the Exchange about appointment of Company Secretary and Compliance Officer of the Company.

Unaudited Financial Results Of The Company For The Quarter And Nine Months Ended December 31 2025

05-Feb-2026 | Source : BSE

Please find attached Unaudited Financial Results for the quarter and nine months ended December 31 2025.

Corporate Actions stock-summary

stock-summary
BOARD MEETING

No Upcoming Board Meetings

stock-summary
DIVIDEND

National Peroxide Ltd has declared 125% dividend, ex-date: 20 Aug 24

stock-summary
SPLITS

No Splits history available

stock-summary
BONUS

No Bonus history available

stock-summary
RIGHTS

No Rights history available

stock-summaryKey Factors

Quality key factors stock-summary

Factor
Value
Sales Growth (5y)
-12.60%
EBIT Growth (5y)
-135.58%
EBIT to Interest (avg)
2.98
Debt to EBITDA (avg)
0.66
Net Debt to Equity (avg)
-0.14
Sales to Capital Employed (avg)
0.87
Tax Ratio
16.30%
Dividend Payout Ratio
42.79%
Pledged Shares
0
Institutional Holding
0.01%
ROCE (avg)
3.99%
ROE (avg)
1.90%

Valuation key factors

Factor
Value
P/E Ratio
NA (Loss Making)
Industry P/E
40
Price to Book Value
0.73
EV to EBIT
-31.12
EV to EBITDA
14.80
EV to Capital Employed
0.68
EV to Sales
0.74
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
-3.43%
ROE (Latest)
-0.80%

Technicals key factors

Indicator
Weekly
Monthly
MACD
Bearish
RSI
No Signal
No Signal
Bollinger Bands
Mildly Bearish
Sideways
Moving Averages
Bearish (Daily)
KST
Bearish
Dow Theory
Mildly Bullish
Bearish
stock-summary Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
stock-summaryShareholding
Shareholding Snapshot : Dec 2025stock-summary
Shareholding Compare (%holding) stock-summary
Majority shareholders

Promoters

Pledged Promoter Holdings

None

Mutual Funds

Held by 0 Schemes

FIIs

Held by 0 FIIs

Promoter with highest holding

Nowrosjee Wadia And Sons Limited (30.78%)

Highest Public shareholder

None

Individual Investors Holdings

24.98%

stock-summaryFinancial
[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Standalone) - Dec'25 - QoQ",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "QoQ Growth in quarter ended Dec 2025 is 1.17% vs 2.45% in Sep 2025",
        "dir": -1
      },
      {
        "prefix": "Standalone Net Profit ",
        "suffix": "QoQ Growth in quarter ended Dec 2025 is 369.23% vs -56.18% in Sep 2025",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Dec'25",
        "Sep'25",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "69.09",
          "val2": "68.29",
          "chgp": "1.17%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "6.99",
          "val2": "4.50",
          "chgp": "55.33%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "0.32",
          "val2": "0.35",
          "chgp": "-8.57%",
          "chgp_class": "positive"
        },
        {
          "field": "Exceptional Items",
          "val1": "-0.58",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Standalone Net Profit",
          "val1": "1.83",
          "val2": "0.39",
          "chgp": "369.23%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "10.12%",
          "val2": "6.59%",
          "chgp": "3.53%",
          "chgp_class": "positive"
        }
      ]
    }
  },
  {
    "link": "half-yearly",
    "btn_text": "All Half Yearly Results",
    "header": "Half Yearly Results Snapshot (Standalone) - Sep'25",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": " Growth in half year ended Sep 2025 is -10.64% vs -6.39% in Sep 2024",
        "dir": -1
      },
      {
        "prefix": "Standalone Net Profit ",
        "suffix": " Growth in half year ended Sep 2025 is -77.78% vs -35.64% in Sep 2024",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Sep'25",
        "Sep'24",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "134.94",
          "val2": "151.01",
          "chgp": "-10.64%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "9.32",
          "val2": "14.33",
          "chgp": "-34.96%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "0.71",
          "val2": "0.88",
          "chgp": "-19.32%",
          "chgp_class": "positive"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Standalone Net Profit",
          "val1": "1.28",
          "val2": "5.76",
          "chgp": "-77.78%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "6.91%",
          "val2": "9.49%",
          "chgp": "-2.58%",
          "chgp_class": "negative"
        }
      ]
    }
  },
  {
    "link": "nine-monthly",
    "btn_text": "All Nine Monthly Results",
    "header": "Nine Monthly Results Snapshot (Standalone) - Dec'25",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in nine months ended Dec 2025 is -4.29% vs -12.97% in Dec 2024",
        "dir": 1
      },
      {
        "prefix": "Standalone Net Profit ",
        "suffix": "YoY Growth in nine months ended Dec 2025 is -26.65% vs -69.10% in Dec 2024",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Dec'25",
        "Dec'24",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "204.03",
          "val2": "213.17",
          "chgp": "-4.29%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "16.31",
          "val2": "17.55",
          "chgp": "-7.07%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "1.03",
          "val2": "1.28",
          "chgp": "-19.53%",
          "chgp_class": "positive"
        },
        {
          "field": "Exceptional Items",
          "val1": "-0.58",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Standalone Net Profit",
          "val1": "3.11",
          "val2": "4.24",
          "chgp": "-26.65%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "7.99%",
          "val2": "8.23%",
          "chgp": "-0.24%",
          "chgp_class": "negative"
        }
      ]
    }
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Standalone) - Mar'25",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Mar 2025 is -13.85% vs -11.41% in Mar 2024",
        "dir": -1
      },
      {
        "prefix": "Standalone Net Profit ",
        "suffix": "YoY Growth in year ended Mar 2025 is -113.40% vs -57.49% in Mar 2024",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Mar'25",
        "Mar'24",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "286.87",
          "val2": "332.99",
          "chgp": "-13.85%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "15.21",
          "val2": "37.60",
          "chgp": "-59.55%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "1.67",
          "val2": "1.98",
          "chgp": "-15.66%",
          "chgp_class": "positive"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Standalone Net Profit",
          "val1": "-2.25",
          "val2": "16.79",
          "chgp": "-113.40%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "5.30%",
          "val2": "11.29%",
          "chgp": "-5.99%",
          "chgp_class": "negative"
        }
      ]
    }
  }
]

Quarterly Results Snapshot (Standalone) - Dec'25 - QoQstock-summary

Dec'25
Sep'25
Change(%)
Net Sales
69.09
68.29
1.17%
Operating Profit (PBDIT) excl Other Income
6.99
4.50
55.33%
Interest
0.32
0.35
-8.57%
Exceptional Items
-0.58
0.00
Standalone Net Profit
1.83
0.39
369.23%
Operating Profit Margin (Excl OI)
10.12%
6.59%
3.53%
Values in Rs Cr.
Direction Arrows
Net Sales

QoQ Growth in quarter ended Dec 2025 is 1.17% vs 2.45% in Sep 2025

Direction Arrows
Standalone Net Profit

QoQ Growth in quarter ended Dec 2025 is 369.23% vs -56.18% in Sep 2025

Half Yearly Results Snapshot (Standalone) - Sep'25stock-summary

Sep'25
Sep'24
Change(%)
Net Sales
134.94
151.01
-10.64%
Operating Profit (PBDIT) excl Other Income
9.32
14.33
-34.96%
Interest
0.71
0.88
-19.32%
Exceptional Items
0.00
0.00
Standalone Net Profit
1.28
5.76
-77.78%
Operating Profit Margin (Excl OI)
6.91%
9.49%
-2.58%
Values in Rs Cr.
Direction Arrows
Net Sales

Growth in half year ended Sep 2025 is -10.64% vs -6.39% in Sep 2024

Direction Arrows
Standalone Net Profit

Growth in half year ended Sep 2025 is -77.78% vs -35.64% in Sep 2024

Nine Monthly Results Snapshot (Standalone) - Dec'25stock-summary

Dec'25
Dec'24
Change(%)
Net Sales
204.03
213.17
-4.29%
Operating Profit (PBDIT) excl Other Income
16.31
17.55
-7.07%
Interest
1.03
1.28
-19.53%
Exceptional Items
-0.58
0.00
Standalone Net Profit
3.11
4.24
-26.65%
Operating Profit Margin (Excl OI)
7.99%
8.23%
-0.24%
Values in Rs Cr.
Direction Arrows
Net Sales

YoY Growth in nine months ended Dec 2025 is -4.29% vs -12.97% in Dec 2024

Direction Arrows
Standalone Net Profit

YoY Growth in nine months ended Dec 2025 is -26.65% vs -69.10% in Dec 2024

Annual Results Snapshot (Standalone) - Mar'25stock-summary

Mar'25
Mar'24
Change(%)
Net Sales
286.87
332.99
-13.85%
Operating Profit (PBDIT) excl Other Income
15.21
37.60
-59.55%
Interest
1.67
1.98
-15.66%
Exceptional Items
0.00
0.00
Standalone Net Profit
-2.25
16.79
-113.40%
Operating Profit Margin (Excl OI)
5.30%
11.29%
-5.99%
Values in Rs Cr.
Direction Arrows
Net Sales

YoY Growth in year ended Mar 2025 is -13.85% vs -11.41% in Mar 2024

Direction Arrows
Standalone Net Profit

YoY Growth in year ended Mar 2025 is -113.40% vs -57.49% in Mar 2024

stock-summaryCompany CV
About National Peroxide Ltd stock-summary
stock-summary
National Peroxide Ltd
Micro Cap
Commodity Chemicals
National Peroxide Limited was formerly incorporated as NPL Chemicals Limited on July 29, 2020, as a Public Limited Company pursuant to a Certificate of Incorporation dated August 5, 2020, issued by the Registrar of Companies, Maharashtra at Mumbai. Through the Composite Scheme of Arrangement, the name of the Company has been changed to National Peroxide Limited and a fresh Certificate of Incorporation dated January 31, 2024, was issued by the Registrar of Companies, Maharashtra at Mumbai.
Company Coordinates stock-summary
Icon
No Company Details Available